9Honerjager P. Pharmacology of bipyridine phosphodiesterase Ⅲ in- hibitors[J]. Am Heart J,1991,121(bpt2) :1939 - 1944.
10MeCullough PA,Phibin EF, Spenus JA,et al. Confirmation of a heart failure epidemic: Findings from the resource utilization among congeslive heart failure(REACH) Study[J]. J Am Cou Car- diol,2003,39(1) :60 - 69.
7Angel Zarain-Herzberg, Jorge Fragoso-Medina, Rafael Estrada-Avil6s, et el. Celclum-regxdated treaxscriptional pathvcays in the normal and pathologic heart [J]. IUBMB Life, 2011, 63(10): 847-855.
8Thomas H Fischer, Jonas Herring, Theodor Tirilomis, et al. Ca2*/ calmoduhn-dependent protein kinase l] and protein kinase h differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology [J]. Circulation, 2013, 128(9) : 970-981.
9Kociol RD, Pang PS, Gheorghiade M, et al. Troponin elevation in heart failure prevalence, mechanisms, and chnical implications [ J ]. Journal of the American College of Cardiology, 2010, 56(14): 1071-1078.
10XING W,LIAO Q,VIBOUD C,et al.Hand,foot,andmouth disease in China,2008-12:an epidemiological study[J].Lan- cet Infect Dis,2014,14(4):308-318.
